Algernon Pharmaceuticals Inc. (CSE: AGN)

Algernon Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 20, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Market Capitalization	2	3	13	17	45	6
Market Cap Growth	8.91%	-79.52%	-24.12%	-62.61%	627.75%	-10.59%
Enterprise Value	2	2	12	13	36	6
Last Close Price	0.09	0.17	1.13	2.09	6.91	2.72
PE Ratio	-	-0.37	-1.30	-1.69	-2.85	-2.57
PB Ratio	1.01	1.77	2.26	1.84	3.67	1.24
P/FCF Ratio	-1.32	-1.02	-4.36	-2.14	-6.78	-3.45
P/OCF Ratio	-1.32	-1.02	-4.36	-2.14	-6.78	-3.45
EV/EBITDA Ratio	-1.20	-0.44	-2.07	-	-4.32	-3.20
EV/EBIT Ratio	-1.19	-0.43	-2.06	-1.71	-4.31	-3.15
EV/FCF Ratio	-1.29	-0.85	-4.06	-1.72	-5.51	-3.17
Quick Ratio	0.32	0.08	0.82	4.60	12.11	0.69
Current Ratio	0.36	0.12	1.12	4.80	12.75	0.76
Return on Equity (ROE)	-91.78%	-191.06%	-82.15%	-72.51%	-99.34%	-59.81%
Return on Assets (ROA)	-35.86%	-50.99%	-39.28%	-42.89%	-58.17%	-33.15%
Return on Capital (ROIC)	-63.27%	-88.61%	-48.70%	-46.16%	-61.46%	-35.36%
Earnings Yield	-134.05%	-260.51%	-47.64%	-46.18%	-19.06%	-30.80%
FCF Yield	-76.01%	-98.08%	-22.92%	-46.71%	-14.76%	-28.96%
Buyback Yield / Dilution	-129.60%	-117.87%	-11.59%	-76.84%	-97.19%	-58.59%
Total Shareholder Return	-129.60%	-117.87%	-11.59%	-76.84%	-97.19%	-58.59%

Source: S&P Capital IQ. Standard template. Financial Sources.